Waltham, MA, United States of America

Pamela Hill

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Pamela Hill in Pharmaceutical Development

Introduction

Pamela Hill, an accomplished inventor based in Waltham, MA, has made significant contributions to the field of pharmaceuticals. With a total of three patents to her name, her work primarily focuses on developing innovative compounds that play a critical role in the treatment of bacterial infections.

Latest Patents

Pamela's most recent patents include:

1. **Antibacterial piperdine derivatives** - This patent details compounds of formula (I) and their pharmaceutically acceptable salts. It outlines the processes for their preparation, pharmaceutical compositions containing them, and their use as medicaments in the treatment of bacterial infections.

2. **Heterocyclic urea derivatives and methods of use thereof** - Similar to her previous patent, this one describes compounds of formula (I) and their pharmaceutically acceptable salts. It further explains the processes for their preparation and the pharmaceutical applications aimed at combatting bacterial infections.

Career Highlights

Pamela is currently affiliated with AstraZeneca AB, a prominent player in the pharmaceutical industry. Her work there has been instrumental in driving forward research and development initiatives focused on innovative healthcare solutions.

Collaborations

Throughout her career, Pamela has collaborated with notable professionals such as Brian A. Sherer and Gregory Steven Basarab. These collaborations highlight the importance of teamwork in the pursuit of medical advancements and invention.

Conclusion

Pamela Hill stands out as a prolific inventor whose expertise in pharmaceutical compounds is helping to shape effective treatments for bacterial infections. With her ongoing contributions at AstraZeneca AB, she continues to validate the significance of innovation in enhancing public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…